Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Inhibition of striatal indirect pathway during second postnatal week leads to long-lasting deficits in motivated behavior
    Published on 2024-09-26
    10 months ago
  • Effects of intranasal oxytocin on fear extinction learning
    Published on 2024-09-24
    10 months ago
  • Vasopressin regulates social play behavior in sex-specific ways through glutamate modulation in the lateral septum
    Published on 2024-09-20
    10 months ago
  • Cathepsin B modulates microglial migration and phagocytosis of amyloid β in Alzheimer’s disease through PI3K-Akt signaling
    Published on 2024-09-20
    10 months ago
  • Role of dorsal striatum circuits in relapse to opioid seeking after voluntary abstinence
    Published on 2024-09-19
    10 months ago
  • Role of serotonin neurons in the dorsal raphe nucleus in heroin self-administration and punishment
    Published on 2024-09-19
    10 months ago
  • Dopamine transmission at D1 and D2 receptors in the nucleus accumbens contributes to the expression of incubation of cocaine craving
    Published on 2024-09-19
    10 months ago
« Previous 1 … 23 24 25 26 27 … 143 Next »
Journal of Psychopharmacology
  • Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants
    Published on 2024-04-15
    1 year ago
  • Psychedelics and the ‘inner healer’: Myth or mechanism?
    Published on 2024-04-12
    1 year ago
  • Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
    Published on 2024-04-05
    1 year ago
  • Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review
    Published on 2024-03-27
    1 year ago
  • Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder
    Published on 2024-03-23
    1 year ago
  • Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression
    Published on 2024-03-23
    1 year ago
  • The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients
    Published on 2024-03-23
    1 year ago
« Previous 1 … 23 24 25 26 27 … 123 Next »
European Neuropsychopharmacology
  • Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
    Published on 2024-04-24
    1 year ago
  • Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials
    Published on 2024-04-21
    1 year ago
  • Schizophrenia patients are not benefiting from worldwide improvements in life expectancy
    Published on 2024-04-21
    1 year ago
  • Cognitive screening in bipolar disorder
    Published on 2024-04-21
    1 year ago
  • Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
    Published on 2024-04-21
    1 year ago
  • Pre-existing chronic physical morbidity and excess mortality in people with bipolar disorder: A population-based cohort study in 2008–2018
    Published on 2024-04-21
    1 year ago
  • The role of anxiety and insomnia in the relationship between COVID-19 perseverative cognition and depression: Parallel and serial mediation analyses
    Published on 2024-04-21
    1 year ago
« Previous 1 … 23 24 25 26 27 … 144 Next »

   Pharma Pub